MD+DI writes about the Levita Magnetics® Series C funding announcement. The $26 million round will be used to support the regulatory and near-term commercial efforts for the Magnetic-Assisted Robotic Surgery (MARS™) platform. Levita also announced the appointment of...
Series C financing to support regulatory process and initial market entry of the Levita® MARSTM platform designed to make robotic surgery accessible for all Menlo Park, California—August 11, 2022—Business Wire—Levita Magnetics, on a mission to provide patients with...
In this episode of the DeviceTalks Weekly Podcast, Levita Magnetics Founder and CEO Alberto Rodriguez-Navarro, M.D. speaks with host Tom Salemi about Levita’s past, present, and future. Hear the origin story of how Alberto developed the Magnetic Surgery System as a...
Menlo Park, California – July 6, 2021 – Business Wire – Levita Magnetics, a company with a mission to improve access to better surgery for more patients, today announced that the first ever robotic-assisted surgical procedures have been performed...
San Mateo, California – January 31, 2019 – Levita Magnetics®, a company dedicated to improving the outcomes of surgical procedures through Magnetic Surgery®, today announced publication of clinical data in Obesity Surgery, the official journal of the International...
San Mateo, California – February 14, 2017 – Levita Magnetics®, the medical technology company that is evolving surgery through Magnetic SurgeryTM, today announced it has been named by Fast Company as one of the Top 10 Most Innovative Companies in Health for 2017. Most...
San Mateo, California – August 17, 2016 – Levita Magnetics, a medical technology company, today released a first-of-its-kind magnetic surgical system. The platform, which recently received CE Mark and FDA clearance, represents one of the key surgical advancements in...
